BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16899112)

  • 1. SNFing HIV transcription.
    Bukrinsky M
    Retrovirology; 2006 Aug; 3():49. PubMed ID: 16899112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.
    Ariumi Y; Serhan F; Turelli P; Telenti A; Trono D
    Retrovirology; 2006 Aug; 3():47. PubMed ID: 16889668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
    Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
    J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter.
    Mahmoudi T; Parra M; Vries RG; Kauder SE; Verrijzer CP; Ott M; Verdin E
    J Biol Chem; 2006 Jul; 281(29):19960-8. PubMed ID: 16687403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrase interactor 1 in health and disease.
    Das S
    Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency.
    Rafati H; Parra M; Hakre S; Moshkin Y; Verdin E; Mahmoudi T
    PLoS Biol; 2011 Nov; 9(11):e1001206. PubMed ID: 22140357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the Brm-type SWI/SNF chromatin remodeling complex is a strong barrier to the Tat-independent transcriptional elongation of human immunodeficiency virus type 1 transcripts.
    Mizutani T; Ishizaka A; Tomizawa M; Okazaki T; Yamamichi N; Kawana-Tachikawa A; Iwamoto A; Iba H
    J Virol; 2009 Nov; 83(22):11569-80. PubMed ID: 19726504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Essential Role of INI1/hSNF5 Chromatin Remodeling Protein in HIV-1 Posttranscriptional Events and Gag/Gag-Pol Stability.
    La Porte A; Cano J; Wu X; Mitra D; Kalpana GV
    J Virol; 2016 Nov; 90(21):9889-9904. PubMed ID: 27558426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
    Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
    J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.
    Deng L; de la Fuente C; Fu P; Wang L; Donnelly R; Wade JD; Lambert P; Li H; Lee CG; Kashanchi F
    Virology; 2000 Nov; 277(2):278-95. PubMed ID: 11080476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin remodeling: from transcription to cancer.
    Yaniv M
    Cancer Genet; 2014 Sep; 207(9):352-7. PubMed ID: 24825771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
    Quivy V; De Walque S; Van Lint C
    Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter.
    Tréand C; du Chéné I; Brès V; Kiernan R; Benarous R; Benkirane M; Emiliani S
    EMBO J; 2006 Apr; 25(8):1690-9. PubMed ID: 16601680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivator of transcription from HIV type 1 subtype E selectively inhibits TNF gene expression via interference with chromatin remodeling of the TNF locus.
    Ranjbar S; Rajsbaum R; Goldfeld AE
    J Immunol; 2006 Apr; 176(7):4182-90. PubMed ID: 16547255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
    Zhao C; Chen Y; Park J; Kim JB; Tang H
    Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varying modulation of HIV-1 LTR activity by Baf complexes.
    Van Duyne R; Guendel I; Narayanan A; Gregg E; Shafagati N; Tyagi M; Easley R; Klase Z; Nekhai S; Kehn-Hall K; Kashanchi F
    J Mol Biol; 2011 Aug; 411(3):581-96. PubMed ID: 21699904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of early steps of HIV-1 replication by SNF5/Ini1.
    Maroun M; Delelis O; Coadou G; Bader T; Ségéral E; Mbemba G; Petit C; Sonigo P; Rain JC; Mouscadet JF; Benarous R; Emiliani S
    J Biol Chem; 2006 Aug; 281(32):22736-43. PubMed ID: 16772295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin remodeling and modification during HIV-1 Tat-activated transcription.
    Pumfery A; Deng L; Maddukuri A; de la Fuente C; Li H; Wade JD; Lambert P; Kumar A; Kashanchi F
    Curr HIV Res; 2003 Jul; 1(3):343-62. PubMed ID: 15046258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.